Adaptimmune Therapeutics PLC at Citi BioPharma Conference (Virtual) Transcript
Great. Thank you, everyone, for joining us today. My name is Mohit Bansal, and I'm one of the biotech analysts here at Citi, and I welcome you all for Citi's 15th Annual Biopharma Virtual Conference. And to kick off my sessions in this conference, we have -- we are pleased to have Adaptimmune management team joining us today. We are joined by Gavin Wood, the CFO; John Lunger, the Chief Patient Supply Officer; Mark Dudley, the SVP of Early stage Development, and also Elliot Norry, MD and Chief Medical Officer of the company. Thank you, all of you for joining us today.
Thank you.
Thank you.
Questions & Answers
Great. So Elliot, this has been a quite eventful year for Adaptimmune. You
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
